In response to the increased burden of prostate cancer, screening programmes are available to mitigate the severity of the disease.7 The most commonly utilised screening tools include digital rectal examinations and prostate-specific antigen (PSA) tests. The gene discussed is KLK3; the disease is prostate cancer.